| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |